David Roberts, Ph.D.   Chief, Biochemical Pathology Section at National Cancer Institute

Dr. Roberts is an expert in CD47 biology and inventor of the technology under development with PSTx. Dr. Roberts received his B.S. in Chemistry from the Massachusetts Institute of Technology and his Ph.D. in Biological Chemistry from The University of Michigan. After postdoctoral training at Michigan and in the Laboratory of Biochemical Pharmacology of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), he became a research chemist in the NIDDK and later joined the NCI as chief of the Biochemical Pathology Section. He serves on peer review panels and on the editorial boards of the Journal of Biological Chemistry, PLoS One, Scientific Reports, and Cellular and Molecular Life Sciences. His research interests include tumor cell-matrix interactions, angiogenesis, redox biology, the biochemistry of cell surface carbohydrates, and host-pathogen interactions.